Big Year For Israeli Tissue Agnostic Company Ayala
The Rehovet-headquartered firm is looking to lead the way for the country's burgeoning biotech sector and take its gamma secretase inhibitors all the way through to Phase III.
The Rehovet-headquartered firm is looking to lead the way for the country's burgeoning biotech sector and take its gamma secretase inhibitors all the way through to Phase III.